Drugs / All-trans Retinoid acid
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00146120 | May 1998 → May 2005 | acute myeloid leukemia | University of Ulm | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00180128 | Jan 2000 → Nov 2012 | acute promyelocytic leukemia | Technical University Dresden | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | all-trans retinoid acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00180128 ↗ |